Gilead Sciences, Inc. (GILD)
144.74
-2.76
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
144.92
+0.18
(+0.12%)
After-Hours: 20:00
Gilead Sciences Price : 144.74 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 147.65 | 148.00 | 144.00 | 144.74 | 5.044M |
| Oct 01, 2026 | 149.44 | 149.44 | 147.18 | 147.50 | 4.439M |
| Sep 30, 2026 | 150.88 | 151.28 | 148.98 | 149.05 | 5.357M |
| Sep 29, 2026 | 150.18 | 152.62 | 148.78 | 151.28 | 5.323M |
| Sep 28, 2026 | 149.80 | 152.74 | 149.41 | 152.21 | 5.082M |
| Sep 25, 2026 | 150.05 | 151.00 | 148.02 | 150.93 | 5.284M |
| Sep 24, 2026 | 151.10 | 152.98 | 149.59 | 149.69 | 5.075M |
| Sep 23, 2026 | 153.60 | 154.20 | 150.06 | 151.37 | 6.192M |
| Sep 22, 2026 | 150.64 | 153.28 | 148.65 | 152.67 | 5.083M |
| Sep 21, 2026 | 150.11 | 152.10 | 148.22 | 150.56 | 5.569M |
| Sep 18, 2026 | 150.56 | 153.23 | 149.57 | 150.11 | 16.42M |
| Sep 17, 2026 | 148.78 | 151.04 | 146.89 | 150.89 | 7.844M |
| Sep 16, 2026 | 146.58 | 149.30 | 146.12 | 147.68 | 5.188M |
| Sep 15, 2026 | 144.00 | 146.35 | 142.94 | 146.30 | 4.536M |
| Sep 14, 2026 | 144.26 | 146.75 | 143.71 | 146.41 | 4.920M |
| Sep 11, 2026 | 145.24 | 145.99 | 143.50 | 143.72 | 4.202M |
| Sep 10, 2026 | 145.07 | 145.91 | 143.67 | 144.81 | 6.020M |
| Sep 09, 2026 | 145.46 | 147.68 | 145.00 | 145.65 | 4.583M |
| Sep 08, 2026 | 146.98 | 148.65 | 145.45 | 146.64 | 6.081M |
| Sep 04, 2026 | 149.23 | 151.18 | 149.23 | 151.00 | 6.182M |
| Sep 03, 2026 | 150.67 | 151.48 | 148.41 | 151.22 | 4.498M |
| Sep 02, 2026 | 150.00 | 152.55 | 148.83 | 149.61 | 4.923M |
| Sep 01, 2026 | 148.52 | 149.96 | 146.92 | 149.92 | 4.871M |
| Aug 31, 2026 | 144.23 | 147.22 | 143.18 | 146.34 | 6.595M |
| Aug 28, 2026 | 149.47 | 149.47 | 144.88 | 145.68 | 3.947M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 262.82 |
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
| Amgen, Inc. | 403.04 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| PS Ratio | 5.928 |
| Price to Book Value | 15.18 |
| Price to Free Cash Flow | 13.99 |
| Earnings Yield | -1.84% |
| Market Cap | 179.62B |
| Operating PE Ratio | 15.18 |
| Normalized PE Ratio | 30.46 |